# Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Multi-Site Phase 2b Clinical Study

> **NCT02933879** · PHASE2 · COMPLETED · sponsor: **Sun Pharmaceutical Industries, Inc.** · enrollment: 184 (actual)

## Conditions studied

- Onychomycosis

## Interventions

- **DRUG:** NVXT topical
- **DRUG:** Placebo (Vehicle) Topical

## Key facts

- **NCT ID:** NCT02933879
- **Lead sponsor:** Sun Pharmaceutical Industries, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-03-21
- **Primary completion:** 2018-03-06
- **Final completion:** 2018-06-21
- **Target enrollment:** 184 (ACTUAL)
- **Last updated:** 2018-12-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02933879

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02933879, "Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Multi-Site Phase 2b Clinical Study". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT02933879. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*